Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease worldwide. People with MASLD can progress to cirrhosis and have an increased risk of developing hepatic decompensation and hepatocellular carcinoma. People with MASLD are also at increased risk of type 2 diabe...
S. Schuth, K. Kantartzis, A. Birkenfeld et al.· Diabetes & Metabolism Jo...· 0 citations
People with MASLD are at increased risk of developing hepatic decompensation and hepatocellular carcinoma, and are also at increased risk of type 2 diabetes mellitus, cardiovascular disease, and chronic kidney disease.
S. Schuth, K. Kantartzis, A. Birkenfeld et al.· 0 citations
Novel findings that measuring CRF before and during a lifestyle intervention may help predict the progression and regression of arteriopathy are provided.
Sebastian Schuth, K. Kantartzis, J. Machann et al.· Atherosclerosis· 0 citations
Kidney transplant patients require intensive follow-up, including monitoring of immunosuppression and screening for complications. Information and communication technologies (ICT) and artificial intelligence (AI) may help optimize and personalize transplant care. We assessed patients’ attitudes toward these technologie...
Felix Eisinger, M. Holderried, Leonie Stauss et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.